SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-028512
Filing Date
2020-10-16
Accepted
2020-10-16 17:00:08
Documents
1
Period of Report
2020-08-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3521
  Complete submission text file 0000899243-20-028512.txt   5169
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 630 W. GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W. GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Marshman Fund Trust II (Reporting) CIK: 0001821461 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 201244524